Acacia Pharma
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Acacia Pharma sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
Acacia Pharma: 9 sponsored US clinical trials, none currently recruiting.
Acacia Pharma sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. 4 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is PONV, with 2 trials.
Top-decile sponsor footprint
Acacia Pharma ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
9 total, page 1 of 1
Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures
NCT04851717
Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients
NCT05546359
PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment
NCT04849650
Study of APD421 as PONV Treatment (Prior Prophylaxis)
NCT02646566
Study of APD421 as PONV Treatment (no Prior Prophylaxis)
NCT02449291
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
NCT02337062
US Phase III Study of APD421 in PONV
NCT01991860
Phase II Dose-ranging Study of APD421 in PONV
NCT01510704
Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV)
NCT00895830
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 4 |
| Phase 3 | 4 |
Therapeutic Areas
How the Acacia Pharma archive is shaped
9 indexed studies, none listed as recruiting (0% open); 8 completed (89%).
Phase mix: 4 late (III/IV) vs 5 early (I/II) (balanced across stages).
Top condition: PONV (2 trials), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Acacia Pharma: archived-pipeline peers nationwide
Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Acacia Pharma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 archived trials
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Acacia Pharma page
9 registered trials is a research-attention snapshot, not an endorsement of Acacia Pharma or any single study.
- None of Acacia Pharma's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- PONV is the condition Acacia Pharma studies most, compare against other sponsors active in the same condition before evaluating a specific study. See PONV trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Acacia Pharma pipeline card: 9 registered trials from official public datasets.Report a data error.